A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?

The objective of the study was to examine whether disease duration independently predicts treatment response among biologic-naïve patients with rheumatoid arthritis (RA) initiating abatacept in clinical practice. Using the Corrona RA registry (February 2006–January 2015), biologic-naïve patients wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Rheumatol
Autores principales: Harrold, Leslie R., Litman, Heather J., Connolly, Sean E., Kelly, Sheila, Hua, Winnie, Alemao, Evo, Rosenblatt, Lisa, Rebello, Sabrina, Kremer, Joel M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer London 2017
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486472/
https://ncbi.nlm.nih.gov/pubmed/28251392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-017-3588-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares